Sign in to view content
Defining Vitreoretinal Interface Diseases
The International Vitreomacular Traction Study Group has helped establish new nomenclature for vitreoretinal interface diseases in order to address the lack of a cogent classification system for diseases of the vitreomacular interface.
In this interview, Netan Choudhry, MD, FRCS(C), Vitreous Retina Macula Specialists of Toronto, interviews study group lead investigator Jay S. Duker, MD, of New England Eye Center, about:
- The group’s approach to developing the nomenclature
- How ocriplasmin can be useful in the treatment of symptomatic vitreomacular adhesion (VMA) and small full-thickness macular holes
- Why retina specialists’ understanding of the pathophysiology of vitreoretinal interface diseases continues to evolve